Trump’s government stock purchases face heightened scrutiny as midterms loom

During the past year the Trump administration adopted an unusual policy of acquiring ownership positions in publicly traded firms, notably Intel, MP Materials and Trilogy Metals, prompting a wave of buying among retail traders who expected sharp price lifts. Initial returns were striking—Intel rose over 300%, MP Materials 87% and Trilogy Metals 73%—though many of those gains have since receded. The strategy now confronts two major challenges: a probable Democratic majority in at least one house of Congress ahead of the midterms, which could lead to hearings and subpoenas, and a shareholder lawsuit contending that the Chips Act does not authorize the government’s equity stakes.

Critics such as Senator Elizabeth Warren and analysts like Henrietta Treyz warn that political scrutiny could damage corporate reputations and depress share prices. A court ruling against the government’s authority would also jeopardize other investments made under the Chips Act. The companies involved have declined to comment, leaving investors to assess the risk that political and legal pressures may undermine earlier stock gains.